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and their behaviour, particularly those driven by climate change or
humanactivities suchasdeforestation,humanbehavioural changes
such as recreative activities that involve close association with
nature, human population increases and the improvements in
surveillance methodologies may contribute to the change in rick-
ettsial diseaseecologyandepidemiology. Since theuseofmolecular
technologies, numerous rickettsiae from kown to unknown or
variable degrees of pathogenicity for humans are being found to
co-circulate in overlapping geographic regions and demonstrated
in the same tick species. Furthermore, the discovery and descrip-
tion of novel nosological entities caused by previously unknown
SFG rickettsiae, ability ofmost rickettsiae to circulate in diverse syl-
vatic or peridomestic reservoirs without having obvious impacts
on their vertebrate hosts or affecting humans, occurance of rick-
ettsiae in association with a wide range of hard and soft ticks
which feed on very different species of large and small animals,
their mmaintenance in these vector systems by both vertical and
horizontal transmission has lead to a degree where the tradi-
tional views of tick-borne rickettsioses as endemic diseases with
largely focal distributions, limited host and geographic ranges, pre-
determined seasonality and deﬁned tick associations to become
obsolete or at least very incomplete. Therefore, continuous vigi-
lance, survailance, research and funding are warranted in order to
understand the changing ecology and epidemiology of rickettsial
diseases.
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Abstract: Rickettsial infections are increasing in all regions of
Southeast Asia where sought. Given the non-speciﬁc presenting
symptoms resembling those of other endemic infections, diagno-
sis can be challenging, even to the most experienced clinician.
Available tests have limitations, with no good gold standard diag-
nostic test. Serological tests are the mainstay of diagnosis with the
IgM indirect immunoﬂuorescence assay being the reference test.
However, the enzyme-linked immuno-sorbent assay is used more
commonly due to the ease of performance and a good sensitiv-
ity and speciﬁcity. Paired samples, obtained at least two weeks
apart, demonstrating a minimum 4 fold titre rise, are needed for
improved serologic speciﬁcity, limiting its clinical feasibility. Other
methods of testing have become available, but at this time, these
remain insufﬁcient to provide the rapid point-of-care diagnostics
that would be necessary to signiﬁcantly change the management
of this infection by providers in endemic areas. The mainstay of
treatment is Doxycycline although the intravenous formulations
are unavailable in several countries. Macrolides have proven efﬁ-
cacy inmild cases and intravenous Azithromycin is used alongwith
oral Doxycycline in seriously ill with suboptimal gastrointestinal
absorption and bioavailability. This presentation reviews the chal-
lenges in the laboratory diagnosis and management of rickettsial
infections unique to Southeast Asia, and examines data on emerg-
ing resistance to antimicrobial drugs.
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Abstract: An effective vaccine against scrub typhus is needed
because of the high incidence (1 million cases annually is likely an
underestimate), large geographic distribution in Asia and islands of
the Indian and Paciﬁc oceans, difﬁculty of diagnosis at the time of
presentation as undifferentiated febrile illness, lack of an effective
low-cost point-of-care diagnostic method to be deployed in rural
areas, case fatality rate of 7-10%, and natural resistance to many
commonly used antibiotics.
Scientiﬁc obstacles to development of a vaccine include great
antigenic diversity of the immunodominant 56 kDa surface protein
antigen that has four major variable domains; weak, short-lived
cross protection against the numerous heterologous strains; loss
of protection against even the homologous strain after a few years;
and poor knowledge of the mechanisms of immune protection,
which are mostly based on studies in an invalid animal model.
Current knowledge indicates that the target cells of intracel-
lular Orientia tsutsugamushi are dendritic cells and macrophages in
themite feeding inoculation lesion (eschar) andmainly endothelial
cells, and secondarily,macrophages in the full-blowndisseminated
infection. Studies in a valid disseminated endothelial cell target
model indicate that CD8 T lymphocytes play an important role.
Earlier studies using the invalid peritoneal infection model suggest
that antibodies to the 56 kDa protein provide protection against
only the homologous strain, cross protection is T cell dependent,
and gamma interferon likely plays an important role. The 47 kDa
and ScaA proteins, which are conserved among strains, stimulate
partial protection.
The critical gaps in knowledge include determining the basis
for insufﬁcient immunological memory triggered by natural infec-
tion, deﬁning the contributions of T lymphocyte subsets, NK cells,
dendritic cells, and various cytokines and chemokines to vaccine-
induced immunity, the orientiacidal mechanisms particularly in
infected endothelial cells, and the prevalence, mechanisms, and
consequences of persistent Orientia infection.
The approach toward vaccine development should utilize the
valid disseminated endothelial cell infection model, bioinformat-
ics identiﬁcationofpotential conservedvaccineantigens, especially
subdominant surface and secreted proteins, and determination of
which novel adjuvants enhance long-lived protective memory T
and B cells. The goal is to do better than nature by stimulating
sterilizing, sustained cross-protection against all strains of O. tsut-
sugamushi.
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